Braavos Investment Advisers is a specialist venture capital firm based in London that manages $500m and invests in companies founded on scientific breakthroughs.
The Series A round was led by Oxford Science Enterprises and Braavos Investment Advisers to support company expansion.
"Through its unique approach, developed by some of the world’s best minds in the quantum space, Oxford Ionics is laying the foundations to finally make quantum computing a scalable, integrable and viable option. Building on more than a decade at the forefront of this sector, Chris, Tom and the team have been able to demonstrate, time and again, that their work in the lab can, and will, extend to the real world and we’re thrilled to be joining them on this journey."
The round was backed by M&G Investments alongside existing supporters Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.
"The Osler Origin platform has the potential to transform healthcare by enabling anyone, anywhere, to access, understand, and act on their healthcare information. This new investment allows us to advance the Osler Origin towards market, and to realise our vision."
